| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/20/2000 | WO2000042073A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | WO2000042027A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 07/20/2000 | WO2000042011A1 Amide compounds |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/19/2000 | EP1020187A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1018878A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040226A2 Method of treating sexual disturbances |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | CA2355967A1 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | CA2354638A1 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | CA2350946A1 Method of treating sexual disturbances |
| 07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2000 | EP1017375A2 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 07/12/2000 | EP0731802B1 N-substituted azabicycloalkane derivatives as neuroleptics etc. |
| 07/12/2000 | CN1259869A Pharmaceutical compositions contg. cinchonine dichlorhydrate |
| 07/11/2000 | US6086878 By administering a gastrointestinal neuromodulator antibody, such as antibodies to bombesin, cholecystokinin, gastrin, somatostatin, and neuropeptide y; for egg or milk-producing animals |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039141A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 07/06/2000 | WO2000039128A1 5ht1 antagonists for antidepressant therapy |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000020025A3 Akt compositions for enhancing survival of cells |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2355097A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues |
| 06/29/2000 | CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/29/2000 | CA2356174A1 Kidney disease detection and treatment |
| 06/29/2000 | CA2356159A1 Novel spla2 inhibitors |
| 06/29/2000 | CA2355902A1 Sulfonamide hydroxamates |
| 06/29/2000 | CA2355704A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
| 06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
| 06/22/2000 | WO2000036105A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | WO2000035474A1 Neurite derived growth factors for use in the treatment of muscular dystrophy |
| 06/22/2000 | WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE |
| 06/22/2000 | WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | CA2355363A1 Prostacyclin-stimulating factor-2 |
| 06/21/2000 | EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms |
| 06/21/2000 | EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/21/2000 | EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009413A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 06/21/2000 | CN1257506A Spiro-quinuclidine derivatives, their preparation and use |
| 06/21/2000 | CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 06/21/2000 | CN1257485A Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 06/21/2000 | CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 06/21/2000 | CN1256918A Application of lotucine in pharmacy |
| 06/20/2000 | US6077846 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
| 06/15/2000 | WO2000034338A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/15/2000 | WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 06/15/2000 | WO2000034313A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | WO2000034295A2 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation |